Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.

VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.

Share this video  

Sleep Europe 2026 | Oveporexton approved for narcolepsy type 1: safety and what to expect in first weeks of treatment

Lucie Barateau, MD, PhD, Gui-de-Chauliac Hospital, CHU Montpellier, Montpellier, France, discusses the safety profile of oveporexton, an orexin receptor 2 (OX2R) agonist approved in the US for the treatment of narcolepsy type 1 (NT1) in adults. Dr Barateau explains that oveporexton is safe and well tolerated, with insomnia and frequent urination being the main side effects. These effects are moderate and transient, resolving within days to weeks, and are outweighed by the benefits of treatment. This interview took place at Sleep Europe 2026 in Maastricht, the Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Actually the safety profile is really really good. This treatment is very well tolerated with a very good safety profile so we can expect a few side effects such as insomnia specifically and also urination so people tend to go to pee a lot. But overall these symptoms are transient so that’s very important to notice that you can be insomniac for a few days but then after a few days and a few weeks it resolves so again they are moderate side effects and then it resolves over time...

Actually the safety profile is really really good. This treatment is very well tolerated with a very good safety profile so we can expect a few side effects such as insomnia specifically and also urination so people tend to go to pee a lot. But overall these symptoms are transient so that’s very important to notice that you can be insomniac for a few days but then after a few days and a few weeks it resolves so again they are moderate side effects and then it resolves over time. And it’s as moderate compared to the benefit that patients will continue on the drug.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.